Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Osteonecrosis × Ferrosoferric Oxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 3 Urinary Bladder Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Osteosarcoma 1 Osteonecrosis 1 Osteomyelitis 1 Lung Carcinoma Metastatic in the Brain 1 Kidney Neoplasms 1 Glioblastoma 1 Cranial Nerve Diseases 1 Chondrosarcoma 1 Central Nervous System Neoplasms 1 Bone Neoplasms 1

Interventions

Zoledronic Acid 1 Surveys and Questionnaires 1 Magnetic Resonance Spectroscopy 1 Interviews as Topic 1 Ferrosoferric Oxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01336803 2023-12-27

Osteosarcoma

Stanford University

Phase 2 Completed

32 enrolled 11 charts

Bone Neoplasms, Chondrosarcoma, Osteomyelitis, Osteonecrosis, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡